- Tumors1000+
- Pathologic Processes1000+
- Nervous System Diseases1000+
- Mental Disorders1000+
- Pathology996
Any
<10 miles
<30 miles
<50 miles
<70 miles
Filter Results
Condition
- Tumors1000+
- Pathologic Processes1000+
- Nervous System Diseases1000+
- Mental Disorders1000+
- Pathology996
Where are you looking?
How far are you willing to travel?Any
How old are you?
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
- HER2 negative
- PD-L1 positive
- ER positive
- HER2 positive
- KRAS positive
- EGFR positive
- BRAF positive
- PR positive
- EGFR negative
- ALK negative
- PD-L1 negative
- ER negative
- PR negative
- BRCA1 positive
- CD20 positive
- IDH positive
- ALK positive
- BRCA2 positive
- BRAF negative
- ROS1 negative
- p16 positive
- HLA-A positive
- HR positive
- TP53 positive
- HLA positive
- MET positive
- ROS1 positive
- CD19 positive
- IDH negative
- NRAS positive
- dMMR positive
- ANA positive
- MSI-H positive
- MYC positive
- NF1 positive
- PALB2 positive
- PIK3CA positive
- anti-dsDNA positive
- p16 negative
- BCR-ABL1 positive
- RAS positive
- HPV negative
- HPV positive
- MET negative
- MSS positive
- RET positive
- KRAS negative
- RET negative
- CFTR positive
- HRAS positive
- NTRK negative
- NTRK positive
- RAS negative
- anti-Sm positive
- ctDNA positive
- BCL2 positive
- FGFR2 positive
- HBsAg positive
- MGMT negative
- TP53 negative
- ATM positive
- BRCA1 negative
- BRCA2 negative
- CCND1 positive
- COL7A1 positive
- DMD positive
- FGFR3 positive
- GPC3 positive
- HLA negative
- HLA-A negative
- KIT positive
- MTAP positive
- PTEN positive
- RB1 negative
- RB1 positive
- ABCA4 positive
- BCL6 positive
- BRCA positive
- CD30 positive
- FMR1 positive
- KMT2A positive
- MDM2 positive
- MGMT positive
- MLH1 positive
- MMR negative
- MSH2 positive
- MSH6 positive
- MSI-H negative
- NPM1 positive
- Ph positive
- Philadelphia chromosome positive
- RF positive
- TROP2 negative
- TROP2 positive
- dMMR negative
- pMMR positive
- APC positive
- APOL1 positive
- APP positive
- ARID1A positive
- CD123 positive
- DLL3 positive
- Ex19del positive
- FGFR positive
- FLT3 positive
- HBB positive
- HBV DNA positive
- HR negative
- HbSS positive
- L858R positive
- MMR positive
- NF2 positive
- NRAS negative
- NUP98 positive
- NY-ESO-1 positive
- PMS2 positive
- PSEN1 positive
- PSEN2 positive
- PiZZ positive
- RAF positive
- RHO positive
- SMARCA4 positive
- SPINK5 positive
- STK11 positive
- T790M positive
- TET2 positive
- anti-AChR positive
- p53 positive
- t(11;14) positive
- 11q negative
- 11q positive
- AChR positive
- AKT negative
- ALPL positive
- ARAF positive
- Anti-PLA2R positive
- Aβ1-42 positive
- BCR::ABL1 positive
- C5 positive
- CD22 positive
- CD30 negative
- CD5 positive
- CDK4 positive
- CHEK2 positive
- CLDN18.2 positive
- COL1A1 positive
- COL1A2 positive
- CRAF positive
- CRLF2 positive
- DMPK positive
- EBV DNA positive
- EBV positive
- EPCAM positive
- FGFR2 negative
- FLT3 negative
- FOXO1 fusion negative
- GRN positive
- H3 K27M positive
- HBV DNA negative
- HBsAg negative
- HEXA positive
- HEXB positive
- HPV16 positive
- HTT positive
- HbSβ0-thalassemia positive
- IGHV positive
- JAK2 positive
- Ki67 positive
- LRRK2 positive
- MECP2 positive
- MSI negative
- MSS negative
- MYD88 L265P positive
- MuSK positive
- NF1 negative
- NTRK1 positive
- PAH positive
- PD-1 negative
- PD-1 positive
- PDE6A positive
- PDE6B positive
- PIK3CA negative
- PIK3CD positive
- PIK3R1 positive
- PKLR positive
- PKP2 positive
- PMM2 positive
- PRSS1 positive
- PSMA positive
- PTCH1 positive
- PTEN negative
- PTPN11 positive
- Philadelphia chromosome negative
- RUNX1 positive
- SMN1 positive
- SOD1 positive
- SOS1 positive
- T315I positive
- TSC1 positive
- TSC2 positive
- Gleason Score 10
- Gleason Score 6
- Gleason Score 7
- Gleason Score 8
- Gleason Score 9
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Stage IV
- Stage III
- Stage II
- Stage I
- 1927nm Fractional Thulium Laser Treatment
- Adjuvant Chemotherapy without Concurrent Biologic/Targeted Therapy
- Adjuvant Therapy (except reconstruction)
- Anti-Seizure Medications (up to 2 types)
- Any Treatment for Pancreatic Cancer
- At least one prior tumor-directed therapy
- Avoidance of Activities That Cause Joint Pain
- Beovu
- Biologic Anti-Neoplastic Agent
- Branch Retinal Vein Occlusion (BRVO)
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
8254 trials
1
2
3
…50